ENDOLOGIX, INC.
|
|||
(Exact name of registrant as specified in its charter)
|
|||
|
|||
Delaware
|
000-28440
|
68-0328265
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
2 Musick, Irvine, CA
|
92618
|
||
(Address of principal executive offices)
|
(Zip Code)
|
||
|
|
||
Registrant’s telephone number, including area code:
(949) 595-7200
|
|||
|
|||
N/A
|
|||
(Former name or former address, if changed since last report)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Votes For
|
Votes Against
|
Votes Abstaining
|
Broker Non-Votes
|
74,003,939
|
4,740,198
|
31,059
|
0
|
|
|
ENDOLOGIX, INC.
|
|
|
|
Date: February 25, 2019
|
|
/s/
Vaseem Mahboob
|
|
|
Vaseem Mahboob
|
|
|
Chief Financial Officer
|